Regorafenib trials for Colorectal cancer

All Regorafenib trials · All Colorectal cancer trials

Phase breakdown

Recruiting trials studying Regorafenib for Colorectal cancer

• Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis
  NCT05057052 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer
  NCT05985109 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer
  NCT05963490 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases
  NCT05794971 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
  NCT05462613 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
  NCT06425133 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
  NCT06047379 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations

Common questions

How many trials study Regorafenib for Colorectal cancer?

7 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.